Company Filing History:
Years Active: 2010
Title: The Innovations of Mark Johnson: Pioneering Drug Discovery through LINGO-1 Research
Introduction: Mark Johnson is an inventive force based in Bridgewater, MA, known for his contributions to the field of pharmacology. As a professional at Wyeth, he has made significant strides in drug discovery and development through his innovative research on LINGO-1 polypeptides, which play a crucial role in various biological processes.
Latest Patents: Mark Johnson holds one notable patent titled "Method for Identifying or Designing a Candidate Agent that Interacts with LINGO-1 Polypeptide Using a LINGO-1 Three-Dimensional Structure." This patent encompasses diverse aspects related to LINGO-1 polypeptides, including their complexes, crystals, and associated methods and software systems. Johnson's work is pivotal in creating agents that can effectively interact with biological targets, fostering advancements in therapeutic solutions.
Career Highlights: During his career at Wyeth, Mark has focused on enhancing drug design and discovery processes. His innovative work has not only propelled research in the pharmaceutical sector but also led to improved understanding of the mechanisms involved with LINGO-1 polypeptides. His singular patent illustrates his commitment to advancing medical science through innovative approaches.
Collaborations: Mark Johnson has collaborated with esteemed colleagues such as Lidia Mosyak and Brian Dwyer. Together, they have made significant contributions in their field, underlying the importance of teamwork in achieving groundbreaking research outcomes. Their diverse expertise in pharmacology and related sciences has enabled them to develop innovative solutions that have the potential to transform therapeutic strategies.
Conclusion: Mark Johnson exemplifies the spirit of innovation through his pioneering work on LINGO-1 polypeptides at Wyeth. With a focus on drug discovery and development, his contributions underscore the importance of scientific research and collaboration in the pursuit of medical advancements. As he continues his work, the implications of his research may lead to significant breakthroughs in understanding and treating various health conditions.